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Detection of pneumococcal antigen has been used to increase the rate of diagnosis of pneumococcal 
pneumonia. The present study was designed to determine the value of rapid detection of pneumococcal 
antigen in samples obtained by transthoracic needle aspiration (TNA) from patients with community- 
acquired pneumonia (CAP) in a comparative analysis with culture and polymerase chain reaction (PCR). 
Pneumococcal antigen was detected by latex agglutination. One hundred and ten consecutive patients 
diagnosed with CAP underwent TNA. Patients were grouped, according to PCR, culture and serological 
results, into pneumococcal pneumonia (n= IS), other known aetiology (n=67) and unknown aetiology 
(72=25). In patients with pneumococcal pneumonia, antigen was detected in 17 (94.4%) cases. Antigen 
was detected in one and nine patients with pneumonia of other known or unknown aetiologies, 
respectively, yielding a specificity of 89.1%. In conclusion, detection of pneumococcal antigen on samples 
obtained by TNA from patients with CAP provides a sensitive and specific diagnosis of Streptococcus 
pneumoniae infection. Furthermore, its rapid results would reduce the dependence on empirical 
treatments. 
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Introduction 
Streptococcus pneumoniae is a major causative 
agent of community-acquired pneumonia (CAP) 
in most series (1). Diagnostic methods currently 
available include examination of blood and 
sputum. A positive blood culture provides the 
basis for a specific aetiologic diagnosis, but its 
sensitivity is low (2). The use of sputum Gram’s 
stain and culture is of uncertain value. The 
ability of a sputum Gram’s test to predict 
sputum culture recovery of pneumococci varies 
widely with the criteria used to define a positive 
Gram’s stain (3). In addition, Gram’s stain 
findings have not been correlated with alveolar 
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cultures in a large number of CAP patients (4). 
Sputum culture also has its limitations, and 
when an organism is recovered with this test, it is 
often impossible to know if the organism is an 
infecting pathogen or a colonizer (5). 
Clinicians are interested in rapid microbio- 
logic methods that provide a specific aetiological 
diagnosis, in spite of prior antibiotic therapy (6). 
Some of this interest has been focused on the 
detection of antigens presented by the patho- 
gens. The development of pneumococcal antigen 
detection tests have proved a good correlation 
with culture of blood and sputum, and provide 
rapid results which do not seem to be modified 
by prior antibiotic therapy (7). However, antigen 
detection in blood or sputum are of limited 
value in both non-bacteriaemic patients and 
non-sputum producers. 
The need for diagnostic procedures that 
by-pass the oropharyngeal tract has allowed a 
re-evaluation of transth0raci.c needle aspiration 
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(TNA), a technique which seems to be specific, 
safe and cost-effective (8). In a low number of 
patients with CAP, some authors have reported 
a good correlation between pneumococcal anti- 
gen detection and culture performed on samples 
obtained by TNA (9). 
In a comparative study with culture and PCR, 
the present authors have investigated the ability 
of agglutination test to detect S. pneumoniae 
capsular antigen in samples obtained by TNA. 
Methods 
The study population consisted of 118 con- 
secutive and non-selected patients admitted at 
emergency room with CAP. Community- 
acquired pneumonia was defined as an acute 
febrile illness with transient shadows on the 
chest radiography. One hundred and ten patients 
out of 118, without major contraindications 
(coagulation disorders, untreatable cough or the 
presence of bullae), underwent TNA. Trans- 
thoracic needle aspiration was performed by a 
technique described previously (10) using an 
ultrathin needle (25 G Spinocan-R) at the 
patient’s bedside with neither radioscopic guid- 
ance nor pre-medication. An expiratory chest 
radiography was performed 2 h later to exclude 
pneumothorax. In all patients, two blood cul- 
tures at admission and serological tests (Myco- 
plasma pneumoniae, Chlamydia pneumoniae, 
Chlamydia psitacci, Legionella pneumophila, 
Coxiella burnetti and Influenza A virus) at Weeks 
1 and 4 were carried out. A four-fold or greater 
increase in IgG antibody titre or, alternatively, a 
stable IgG titre 2512 by immunofluorescence 
(M. pneumoniae, C. pneumoniae and L. pneumo- 
phila) or 220 by complement fixation test 
(C. psitacci, C. burnetti, Influenza A virus) were 
considered diagnostic. 
The sample obtained by TNA was sent to 
the bacteriology laboratory and processed by the 
following methods: 
(1) Twenty-five microlitres were boiled and 
centrifuged for 3 min. Capsular pneumococcal 
antigens were investigated by a latex agglutin- 
ation test. Antisera for S. pneumoniae (Slidex 
Meningite Kit; Bio-Merieux, Marcy l’Etoile, 
France) were used. Positive and negative 
controls were used in each determination. 
(2) A total of 0.5 ml was washed three times 
with distilled water in order to obtain total lysis 
of red blood cells. Subsequently, the sample was 
centrifuged and the pellet was re-suspended in 
300~1 lysis buffer (0.01 M Tris HCl, pH 7.8, 
0.005 M EDTA) and incubated for 1 h at 37°C 
with 0.5% sodiumdodecyl sulphate (SDS) and 
1.5~1 of proteinase K. The sample was subse- 
quently mixed with 400 ~1 phenol-chloroform 
and centrifuged at 12.000 rpm for 5 min in order 
to separate organic and aqueous phases. The 
sample was placed in a 1.5 ml tube, precipitated 
with 0.6 volumes of isopropyl alcohol and incu- 
bated for 10 min at room temperature. Further, 
the tube was centrifuged at 12.000 rpm for 
10 min, and the sample was decanted and 
washed with 70% ethanol; it was then centri- 
fuged at 12.000 rpm for 10 min and the super- 
natant was removed. Finally, DNA was 
re-suspended in 100 ,ul distilled water. For DNA 
amplification, the primer set Pn2x up (CGT 
GGG ACT ATT TAT GAC CGA AAT GG) 
and Pn2x down (AAT TCC AGC ACT GAT 
CGA AAT AAA CAT ATT A) were used, that 
amplified the PBP 2x gene of S. pneumoniae as 
described previously (11). The amplification was 
performed in a thermocycler (Mod. IHB2024, 
Cherlyn Electronics Ltd., Cambridge, U.K.), 
heating the sample one cycle at 95°C for 4 min, 
then 40 cycles at 95°C for 1.5 min at 56°C for 
1.5 min and at 72°C for 6 min, and finally, one 
cycle at 70°C for 10 min. The amplified product 
was analysed by 3% agarose gel electrophoresis 
and ethidium bromide staining, and examined 
by ultra-violet transillumination. To prevent 
contamination, a strict spatial separation of the 
different technical steps involved in polymerase 
chain reaction (PCR) was maintained during the 
process, and the recommendations of Kwok and 
Higuchi were followed (12). Positive and nega- 
tive controls were used in each determination. 
SENSITIVITY OF PCR 
Serial dilutions of 150, 100, 54, 11 and 
5 cfu ml - ’ S. pneumoniae in both blood-agar 
and TNA samples were tested by PCR. The test 
was positive at all dilutions in blood-agar, 
whereas it was positive on 150, 100, 54 and 
5cfuml-’ S. pneumoniae dilution and negative 
at 11 cfu ml - ’ S. pneumoniae dilution. 
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TABLE 1. Diagnostic yield in 110 patients with 
community-acquired pneumonia who underwent 
transthoracic needle aspiration 
Known aetiology 85 (77.2%) 
Clzlamydia spp 22 (20%) 
Streptococcus pneumoniae 18 (16.3%) 
Mycoplasma pneumoniae 18 (16.3%) 
Pneumocystis carinii 7 (6.3%) 
Influenza A virus 7 (6.3%) 
Haemoplzilus influenzae 6 (5.4%) 
Mycobacterium tuberculosis 3 (2.7%) 
Coxiella buvnetti 2 (1.8%) 
Streptococcus viridans 1 (0.9%) 
Enterococcus faecium I (0.9%) 
Unknown aetiology 25 (22.8%) 
(3) The remaining sample was investigated for 
special pathogens by standard techniques (13). 
The diagnosis of pneumococcal pneumonia 
was made on the basis of at least one of the 
following: (1) positive blood culture; (2) positive 
TNA culture; and (3) positive PCR test on TNA 
sample. 
The rapid results of latex agglutination guided 
the antibiotic therapy. If positive, penicillin at 
standard dosage was added; if negative, epi- 
demiological features and clinical situation of 
the patient guided the choice of antibiotic. 
This study was approved by the Ethics Com- 
mittee of the hospital, and guidelines for human 
experimentation from the Spanish Department 
of Health were followed. In addition, informed 
consent was obtained from the patients. 
Results 
An aetiological diagnosis was established in 85 
(77.2%) patients as shown in Table 1. Strepto- 
coccus pneumoniue was considered responsible in 
18 (16.3%) patients. There were 12 men and six 
women of mean age of 56.7 years (range 26687). 
Eleven (61.1%) patients had underlying disease 
(AIDS in five patients, lung cancer in four 
patients, chronic bronchitis in one patient, and 
dementia in one patient). AIDS patients had a 
mean CD4+ lymphocytes count of 151 mm - 3 
(range 5430). Before admission, seven (38.8%) 
of the patients had received antibiotic treatment. 
TABLE 2. Results of diagnostic tests performed on 18 
patients with pneumococcal pneumonia 
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TNA, transthoracic needle aspiration; F’CR, polymer- 
ase chain reaction. 
Eight of them (44.4%) had respiratory failure 
WA 160 mmHg), but none underwent 
mechanical ventilation. An 8 l-year-old patient 
with severe pneumonia and without evidence of 
pneumothorax in relation to TNA died within 
24 h of admission. 
Table 2 shows the results of the diagnostic 
tests in patients with pneumococcal pneumonia. 
Blood culture, TNA culture, PCR and antigen 
detection tests were positive in 9, 7, 15 and 17 
cases, respectively. Evidence of pneumococcal 
infection by either culture and/or PCR was 
found in 18 of the cases, and in 17 of these, the 
antigen detection test was positive, yielding a 
sensitivity of 94.4%. 
In 66 of 67 patients with pneumonia caused 
by other known micro-organisms, the antigen 
detection test was negative. One patient with 
serologic evidence of C. pneumoniae in- 
fection had a positive result of the antigen 
detection test. In nine (36%) of 25 patients with 
pneumonia of unknown aetiology, the result of 
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the agglutination test was positive, and they were 
all treated with penicillin. The specificity was 
then calculated as 89.1%. 
Complications from TNA procedure were 
seen in eight (7%) cases; three (2.6%) patients 
developed pneumothorax less than 20% (pleural 
drainage was not required), and five (4.4%) 
patients had mild-autolimited haemoptysis. 
Discussion 
Antigen detection tests have been widely used in 
a variety of body fluids in clinical studies (7). The 
frequency of a positive pneumococcal antigen 
test in pneumococcal pneumonia varies con- 
siderably depending on both the body fluid 
investigated and the antigen detection method 
performed. Sensitivities have ranged between 
40-99, 9-76 and 576% in sputum, serum and 
urine samples, respectively (14-19). Latex agglu- 
tination (LA) and co-agglutination (COA) tech- 
niques are about 5-10 times more sensitive 
in vitro than countercurrent immunoelectro- 
phoresis (CIE) (20) and ELISA technique is 
c. 5-10 times more sensitive than agglutination 
methods, but batch processing is necessary on 
economic grounds, the test is time-consuming, 
and non-specific reactivity has been trouble- 
some, especially with urine specimens (21). 
The conclusion from these studies is that 
pneumococcal antigen is most often found in 
sputum. However, the diagnostic specificity of 
pneumococcal antigens found in sputum is 
uncertain. As with sputum culture, expectorated 
samples could conceivably be contaminated by 
antigens derived from S. pneumoniae colonizing 
the oropharynx. It has been shown that in the 
absence of active lower respiratory tract infec- 
tion, oropharyngeal organisms produce antigens 
in saliva, giving positive pneumococcal antigen 
reactions in 20% of healthy volunteers (7). 
The diagnostic specificity for pneumococcal 
infection of pneumococcal antigens in serum, 
urine or pleural effusion is undoubted. However, 
not all patients with pneumococcal pneumonia 
become antigenaemic, thereby limiting the sensi- 
tivity. Boersma et al. (22) performed pneumo- 
coccal antigen test on pleural fluid from 33 
patients with CAP. The test was positive in 
89% of cases with pneumococcal pneumonia. 
However, pneumonia due to S. pneumoniae are 
associated with parapneumonic effusion in only 
40% of cases (23). Recently, pneumococcal 
antigen tests have been investigated on samples 
obtained by invasive techniques. Jimenez et al. 
(24) have performed the LA test on broncho- 
alveolar lavage samples from 59 patients with 
CAP. Pneumococcal antigen was detected in 
54% of pneumococcal pneumonia cases, and no 
false positive results were found. Unfortunately, 
bronchoscopy is uncomfortable for the patient, 
and specialized personnel is required (25). There- 
fore, TNA appears to be a cost-effective method 
to obtain uncontaminated samples from lung 
parenchyma (26), and in the present study it was 
performed in 110 (93.2%) of 118 unselected 
patients with CAP. Recently (9), 12 patients with 
pneumococcal pneumonia underwent TNA, and 
the pneumococcal antigen detection test was 
positive in 10 (83.3%) without false positive 
results. In the present study, 17 of 18 pneumo- 
coccal pneumonia cases had a positive antigen 
test, yielding a sensitivity of 94.4%. In 67 
patients with pneumonia caused by a micro- 
organism other than S. pneumoniae, the aggluti- 
nation test was positive in only one patient. In 
this patient, acute and convalescence antibody 
titres were considered to be diagnostic for 
C. pneumoniae infection. However, the results of 
a recent study using PCR techniques (27) raised 
a concern about the specificity of serology for 
diagnosing active infection with C. pneumoniae, 
since 18% of asymptomatic patients had diag- 
nostic antibody titres indicating acute infec- 
tion. Otherwise, evidence of mixed infections 
has already been described (28-30), and this 
possibility could be existent in the above patient. 
In up to 50% of patients with CAP, the 
microbial aetiology is never determined. It has 
been postulated that other agents causing pneu- 
monia remain to be discovered (1). Alternatively, 
it has been suggested that most patients with 
pneumonia of unknown aetiology have pneumo- 
coccal pneumonia (3 1). The present results are in 
accordance with the latter explanation, since 
36% of the study patients with pneumonia of 
unknown aetiology had pneumococcal antigen 
detected in TNA samples, and they were all 
cured when penicillin was added. Similarly, 
Jimenez et al. (24) found that the test was 
positive in 53% of cases with pneumonia of 
unknown aetiology, from samples obtained by 
bronchoscopy. 
In this regard, some of the PCR negative 
results could have been false negative results. 
The sensitivity with which PCR amplifies 
5’. pneumoniae DNA varies to the primers used, 
the body fluid studied and the ability to remove 
the polymerase inhibitors from the sample. 
Thus, the sensitivity of PCR was 633100% when 
the product amplified was the pneumolysin gene, 
and 75% when the autolysine gene was used in 
blood cultures (32,33). In sputum, PCR has 
demonstrated a 93% correlation with sputum 
culture (bacterial counts of lo7 cfu ml - ‘) (34). 
In addition, the incomplete removal of DNA 
polymerase inhibitors may constitute an expla- 
nation for variable PCR results (35) and the 
present PCR results in vitro (see Methods). 
In summary, these data demonstrate the possi- 
bility to detect S’. pneuwzoniae antigen on TNA 
samples with a high sensitivity, and accumulat- 
ing evidence suggests that the specificity is good. 
Furthermore, the rapid result would reduce 
the dependence on empirical antimicrobial 
treatments. 
References 
1. Fang G, Fine M, Orloff J et al. New and emerg- 
ing etiologies for community-acquired pneu- 
monia with implications for therapy. A prospec- 
tive multicenter study of 359 cases. Medicine 
(Baltj 1990: 69: 307-316. 
2. Research Committee of British Thoracic Society 
and Public Health Laboratory Service. 
Community-acquired pneumonia in adults in 
British hospitals 1982-1983: a survey of aetiol- 
ogy, mortality, prognostic factors and outcome. 
Q J Med 1987; 239: 195-220. 
3. Rein MF, Gwaltney JM, O’Brien WM et al. 
Accuracy of Gram’s stain in identifying pneumo- 
cocci in sputum. JAMA 1978; 239: 2671-2673. 
4. Niederman MS, Bass JB Jr, Campbell GD et al. 
Guidelines for the initial management of adults 
with community-acquired pneumonia: diagnosis, 
assessment of severity, and initial antimi- 
crobial therapy. Am Rev Respir Dis 1993; 148: 
1418-1426. 
5. Lentino JR, Lucks DA. Nonvalue of sputum 
culture in the management of lower respiratory 
tract infections. J Clin Microbial 1987; 25: 
758-762. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
DETECTIONOFPNEUMOCOCCALANTIGEN 205 
Ausina V. Rapid laboratory diagnostic methods 
in respiratory infections. CI.U~ Opin Infect Dis 
1989; 2: 541-546. 
Venkatesan P, Macfarlane JT. Role of pneumo- 
coccal antigen in the diagnosis of pneumococcal 
pneumonia. Thorax 1992; 47: 3299331. 
Zalacain R, Llorente L, Gaztelurrutia L et al. 
Puncion transtoracica aspirativa con aguja 
ultra&a en neumonias de alto riesgo adquiridas 
en la comunidad. Med Clin (Barcj 1993; 100: 
567-570. 
Bella F, Tort J, Morera MA, Espaulella J, 
Armengol J. Value of bacterial antigen detection 
in the diagnostic yield of transthoracic needle 
aspiration in severe community-acquired 
pneumonia. Thorax 1991; 46: 1227-1229. 
Manresa F, Dorca J. Needle aspiration tech- 
niques in the diagnosis of pneumonia. Thorax 
1991;46: 601-603. 
Dowson CG, Hutchinson A, Spratt BG. Exten- 
sive remodelling of the transpeptidase domain of 
penicillin-binding protein 2B of a penicillin- 
resistant South African isolate of Streptococcus 
pneumoniae. Mol Microbial 1989; 3: 95-102. 
Kwok SK, Higuchi R. Avoiding false positivities 
with PCR. Nature (London) 1989; 339: 237-238. 
Ballows A, Hausler WJ, Herrmann KL, Isenberg 
HD, Shadomy HJ. Manual of Clinical Micro- 
biology (5th edn). Washington: American Society 
for Microbiology, 199 1. 
Farrington M, Rubenstein D. Antigen detection 
in pneumococcal pneumonia. J Infect Dis 1991; 
23: 109-116. 
ijrtqvist A, Jiinsson I, Kalin M, Krook A. 
Comparison of three methods for detection of 
pneumococcal antigen in sputum of patients with 
community-acquired pneumonia. Eur J Clin 
Microbial Infect Dis 1989; 8: 956-961. 
Boersma WG, Liiwenberg A, Holloway Y: 
Kutschriitter H, Snidjer JAM, KoCter GH. 
Pneumococcal capsular antigen detection and 
pneumococcal serology in patients with 
community-acquired pneumonia. Thorax 1991; 
46: 902906. 
Mcfarlane JT, Finch RG, Ward MJ, Macrae AD. 
Hospital study of adult community-acquired 
pneumonia. Lancet 1982; ii: 255-258. 
18. Coonrod JD; Drennan DP. Pneumococcal 
pneumonia: capsular antigenaemia and antibody 
responses. Ann Intern Med 1976; 84: 254-260. 
19. Tugwell P, Greenwood PM. Pneumococcal anti- 
gen in lobar pneumonia. J Clin Path01 1975; 25: 
118-123. 
20. Harding SA, Brown DC. Streptococcus pneu- 
moniae. In: Kohler RB, ed. Antigen Detection to 
206 A.RuIz-GONZALEZ ET AL 
Diagnose Bacterial Infections. Boca Raton, 
Florida: CRC Press, 1986, pp. 27-38. 
21. Doskeland SO, Berdal BP. Bacterial antigen 
detection in body fluids: methods for rapid 
antigen concentration and reduction of non- 
specific reactions. J Clin Microbial 1980; 11: 
380-384. 
22. Boersma WG, Liiwenberg A, Holloway Y, 
Kuttschriitter H, Snidjer JAM, KoEter GH. 
Rapid detection of pneumococcal antigen in 
pleural fluid of patients with community- 
acquired pneumonia. Thorax 1993; 48: 160-162. 
23. Light RW, Girard WM, Jenkinson SG, George 
RB. Parapneumonic effusions. Am J Med 1980; 
69: 507-5 11. 
24. Jimenez P, Meneses M, Saldias F, Velasquez M. 
Pneumococcal antigen detection in broncho- 
alveolar lavage fluid from patients with pneu- 
monia. Thorax 1994; 49: 872-874. 
25. Khan FW, Jones JM. Diagnosing bacterial res- 
piratory infections by bronchoalveolar lavage. 
J Infect Dis 1987; 155: 862-869. 
26. Falguera M, Nogues A, Ruiz-Gonzalez A, 
Garcia M, Puig T, Rubio-Caballero M. Trans- 
thoracic needle aspiration in the study of pul- 
monary infections in patients with AIDS. Chest 
1994; 106: 697-702. 
27. Gaydos CA, Roblin PM, Hammerschlag MR 
et al. Diagnostic utility of PCR-enzyme 
immunoassay, culture and serology for detection 
of Chlamydia pneumoniae in symptomatic and 
asymptomatic patients. J Clin Microbial 1994; 32: 
903-905. 
28. ijrtqvist A, Hedlund J, Grillner L et al. 
Aetiology, outcome and prognostic factors in 
community-acquired pneumonia requiring hos- 
pitalization. Eur Respir J 1990; 3: 1105-l 113. 
29. Brown RB, Sands M, Ryczak M. Community- 
acquired pneumonia caused by mixed aerobic 
bacteria. Chest 1986; 90: 810-814. 
30. Almirall J, Morato I, Riera F et al. Incidence of 
community-acquired pneumonia and Chlamydia 
pneumoniae infection: a prospective multicentre 
study. Eur Respir J 1993; 6: 14-18. 
31. Farr BM, Kaiser DL, Harrison BDW, Connolly 
CK. Prediction of microbial etiology at 
admission to hospital for pneumonia from the 
presenting clinical features. Thorax 1989; 44: 
1031-1035. 
32. Rudolph KM, Parkinson AJ, Black CM, 
Mayer W. Evaluation of polymerase chain reac- 
tion for diagnosis of pneumococcal pneumonia. 
J Clin Microbial 1993; 31: 2661-2666. 
33. Hassang-king M, Baldeh I, Secka 0, Falade A, 
Greenwood B. Detection of Streptococcus 
pneumoniae DNA in blood cultures by PCR. 
J Clin Microbial 1994; 32: 1721-1724. 
34, Gillespie SH, Ullman C, Smith MD, Emery V. 
Detection of Streptococcuspneumoniae in sputum 
samples by PCR. J Clin Microbial 1994; 32: 
1721-1724. 
35. Higuchi R. Simple and rapid preparation of 
samples for PCR. In: Erlich HA, ed. PCR 
Technology. Principles and Applications for DNA 
Amplification. New York: Stockton Press, 1988, 
pp. 31-38. 
